Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses

Morbidity and mortality resulting from influenza-like disease are a threat, especially for older adults. To improve case management, next-generation broad-spectrum antiviral therapeutics that are efficacious against major drivers of influenza-like disease, including influenza viruses and respiratory...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Yoon, Jeong-Joong, Toots, Mart, Lee, Sujin, Lee, Myung-Eun, Ludeke, Barbara, Luczo, Jasmina M., Ganti, Ketaki, Cox, Robert M., Sticher, Zachary M., Edpuganti, Vindya, Mitchell, Deborah G., Lockwood, Mark A., Kolykhalov, Alexander A., Greninger, Alexander L., Moore, Martin L., Painter, George R., Lowen, Anice C., Tompkins, Stephen M., Fearns, Rachel, Natchus, Michael G., Plemper, Richard K.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2018
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6105843/
https://ncbi.nlm.nih.gov/pubmed/29891600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00766-18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky